Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Chronic Inflammatory Demyelinating Polyneuropathy
Clinical trial register · United States · industry-sponsored

Chronic Inflammatory Demyelinating Polyneuropathy Trials in the USA, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9132 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 10 Oct 2026, 03:16 UTC
9132
Studies in scope
industry-sponsored, all four open statuses
4964
Recruiting now
open to new participants
2194
Lead sponsors
across recruiting studies
Top states
California 6 Florida 6 Alabama 4 Colorado 4 Connecticut 4
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Chronic Inflammatory Demyelinating Polyneuropathy trials in the USA

7 of 9132 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
Kedrion S.p.A.
Phase 3
161
Connecticut, Florida, New Hampshire, Texas
2026-10
Recruiting
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
NCT07304154Chronic Inflammatory Demyelinating Polyneuropathy, Myasthenia Gravis, Multiple Sclerosis
Kite, A Gilead Company
Phase 1
52
California, New York, Utah, Washington
2026-04-10
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
argenx
Phase 3
160
Alabama, California, Colorado, District of Columbia, Florida, Louisiana, Pennsylvania, Tennessee
2025-09-16
Recruiting
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
NCT06920004Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
argenx
Phase 3
218
Alabama, California, Colorado, District of Columbia, Florida, Kentucky, Louisiana, Maryland
2025-08-22
Recruiting
Immunovant Sciences GmbH
Phase 2
162
Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Illinois, Kansas
2025-03-18
Recruiting
Dianthus Therapeutics
Phase 3
256
Alabama, Arizona, California, Connecticut, District of Columbia, Florida, Hawaii, Illinois
2025-02-10
Recruiting
Sanofi
Phase 3
160
Alabama, Arizona, California, Colorado, Connecticut, Florida, Illinois, Kansas
2024-08-21
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-usa/condition/chronic-inflammatory-demyelinating-polyneuropathy

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,132 studies in total at the last sync on 10 Oct 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies listing the condition Chronic Inflammatory Demyelinating Polyneuropathy.

How many Chronic Inflammatory Demyelinating Polyneuropathy trials are recruiting in the US?

7 of the 7 studies on this page are recruiting new participants as of the 10 Oct 2026, 03:16 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chronic Inflammatory Demyelinating Polyneuropathy), 7 studies
PhaseStudiesRecruitingShare
Phase 35571.4%
Phase 11114.3%
Phase 21114.3%

Most active sponsors

Lead sponsors with the most studies (Chronic Inflammatory Demyelinating Polyneuropathy)
Lead sponsorStudiesRecruiting
argenx22
Dianthus Therapeutics11
Immunovant Sciences GmbH11
Kedrion S.p.A.11
Kite, A Gilead Company11
Sanofi11

Top states

Top states (Chronic Inflammatory Demyelinating Polyneuropathy), by number of studies with a site there
StateStudies
California6
Florida6
Alabama4
Colorado4
Connecticut4
District of Columbia4
Arizona3
Illinois3
Kansas2
Louisiana2
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.